Standard Biotools Inc Strategic Asset Allocation Index
Standard Biotools Inc strategic asset allocation index. Standard Biotools Inc (LAB) has a Strategic Asset Allocation Index of 12.5% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $67.28 Million) total $67.28 Million, measured against net assets of $539.97 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See LAB net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Standard Biotools Inc (2016–2025)
Strategic asset allocation index of Standard Biotools Inc from 2016 to 2025. This chart shows how Standard Biotools Inc's Strategic Asset Allocation Index has evolved across 8 annual periods from 2016 to 2025. As of June 2026, the index stands at 12.5%, representing strategic assets of $67.28 Million against net assets of $539.97 Million USD. Check LAB tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Standard Biotools Inc Strategic Asset Allocation Index by Year (2016–2025)
Standard Biotools Inc strategic asset allocation index by year from 2016 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Standard Biotools Inc from 2016 to 2025, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Standard Biotools Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 6.1% | $25.70 Million | $- | $25.70 Million | $424.29 Million | ▲ +6.1 pp |
| 2024 | 0.0% | $0.00 | $- | $0.00 | $471.72 Million | ▼ -68.9 pp |
| 2021 | 68.9% | $65.15 Million | $65.15 Million | $- | $94.60 Million | ▲ +28.9 pp |
| 2020 | 40.0% | $55.65 Million | $55.65 Million | $- | $139.05 Million | ▲ +31.6 pp |
| 2019 | 8.4% | $12.92 Million | $12.92 Million | $- | $153.61 Million | ▼ -3.8 pp |
| 2018 | 12.2% | $8.82 Million | $8.82 Million | $- | $72.12 Million | ▼ -27.5 pp |
| 2017 | 39.8% | $12.30 Million | $12.30 Million | $- | $30.93 Million | ▲ +8.7 pp |
| 2016 | 31.0% | $16.52 Million | $16.52 Million | $- | $53.23 Million | — |